ICD-10-CM Billable Code

F18.92

Inhalant use, unspecified with intoxication

Clinical Classification Guidelines

Medical Intelligence & Overview

Inhalant use with intoxication, classified under ICD-10 code F18.92, refers to the harmful use of aromatic or chemical substances inhaled to achieve a psychoactive effect. This condition can lead to significant health issues, including acute intoxication, prolonged substance dependence, and serious physical and mental health consequences. Recognizing the signs and understanding the implications of inhalant intoxication are crucial for early intervention and treatment.

Causes & Symptoms

Clinical Causes: Curiosity or experimentation with chemicals among adolescents and young adults Peer pressure and social influences encouraging substance use Attempting to achieve a quick high or escape from everyday stress or emotional problems Lack of awareness about the dangers associated with inhalant use Underlying mental health conditions that increase susceptibility to substance experimentation

Key Symptoms: Dizziness or lightheadedness Euphoria or feeling of being high Nasal discomfort or nosebleeds Headaches Slurred speech and poor coordination Nausea and vomiting Visual disturbances Confusion or disorientation Lethargy or fatigue In severe cases, loss of consciousness and seizures

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a comprehensive clinical assessment, which includes discussing the patient’s substance use history, observing physical signs, and conducting laboratory tests if necessary. Blood, urine, or breath tests can detect the presence of inhalant chemicals. Medical professionals also evaluate for signs of intoxication and any complications arising from inhalant use.

Treatment Protocols: Treatment typically includes medical and psychological interventions. Immediate care focuses on managing acute intoxication symptoms and any resulting health complications, such as respiratory issues or neurological effects. Long-term recovery may involve behavioral therapies, counseling, and support groups aimed at addressing underlying causes and preventing relapse. Education about the risks of inhalant use is also an integral part of recovery.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is F18.92 a billable ICD-10 code?
Yes, F18.92 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report F18.92?
Clinical documentation must specify the nature of Inhalant use, unspecified with intoxication and any associated comorbidities for accurate reporting.

Cite this Clinical Reference